|
|
 |
|
Viewing report
|
|
|
|
Generic and Biogeneric Drugs for 15 Major Therapeutic Categories: U.S./E.U./Japan/ROW Market Trends and Directions 2008-2013 (Japanese Version)
Fuji-Keizai USA, Inc., Jan 2010, Pages: 269
This report reviews, analyzes and sizes the generic and biogeneric drug markets, particularly focusing on new biogeneric medicines.
This report assesses the generic prescription market and maps the competitive landscape. The market forecast section sizes the market and discusses the five-year revenue projection to 2013. The market is segmented by key therapeutic applications, into major world regions of U.S., EU, Japan and rest of world (ROW), with drugs identified by active ingredient and brand name (in parentheses). It covers the major therapeutic indications for generic medicines:
- Allergy Drugs
- CNS and Psychotherapeutic Drugs
- Analgesics, NSAIDs and Antirheumatic Drugs
- Cholesterol Reducers
- Anesthesia Drugs
- Diabetes Drugs
- Anti-Convulsants
- Gastrointestinal Drugs
- Anti-Infectives
- Hormonal Drugs
- Cancer Drugs
- Osteoporosis Drugs
- Cardiovascular Drugs
- Sleeping Agents & Sedatives
Primary information for this report was gathered from numerous sources including in-person interviews and discussions, telephone interviews, and surveys, attendance at business presentations at healthcare technical and financial conferences as well as through secondary research.
This market research study is designed for people that include marketers, business development, top executives, investors, VCs, consultants, R&D managers, entrepreneurs and the like. More than 200 detailed tables and figures provide key data about items such as revenues and market size, market share, segments and the like. This report includes 37 company profiles that provide the reader a snapshot of the companies' focus or activities. Internet links help readers access companies' own web sites for further review.
Targeted Company:
- Actavis Group
- Analiza Inc.
- Apotex
- Aurobindo Pharma
- Bedford Laboratories
- Biocon
- BioGeneriX Ag
- Biopartners GmbH
- Cangene Corporation
- Dr. Reddy’s Laboratories
- Dragon Pharmaceuticals Inc.
- Hospira Inc.
- Lupin Pharmaceuticals
- Microbix Biosystems
- Momenta Pharmaceuticals
- Mylan Inc.
- Nichi-Iko Pharmaceutical
- Nipro Pharma Corp.
- Orchid Chemicals and Pharmaceuticals Ltd.
- Par Pharmaceuticals
- Perrigo
- Pfizer
- Phage Biotechnology Corp.
- Ranbaxy Laboratories
- Ratiopharm
- Reliance GeneMedix plc
- Roxane Laboratories
- Sandoz
- Sawai Pharmaceutical Co.
- Stada Arzneimittel Ag
- Taisho Pharmaceutical Industries
- Taro Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Towa Pharmaceutical
- URL Pharma
- Watson Pharmaceuticals Inc.
- Zydus Pharmaceuticals Inc.
This title is also available in the following language
Generic and Biogeneric Drugs for 15 Major Therapeutic Categories: U.S./E.U./Japan/ROW Market Trends and Directions 2008-2013 (English Version)
Customers who bought this item also bought
Generic and Biogeneric Drugs for 15 Major Therapeutic Categories: U.S./E.U./Japan/ROW Market Trends and Directions 2008-2013
Juvenile Idiopathic Arthritis (JIA): KOL Insights on Treatment Practices and Unmet Needs
Drugs of Abuse Testing Markets
Japan Pharmaceutical Industry & Forecast-Focus on OTC and Prescription Drugs Market
Pharmaceutical and Healthcare Market in Poland 2011. Development Forecasts for 2011-2013
Pharmaceutical and Healthcare Market in Poland 2011. Development Forecasts for 2011-2013
Saudi Arabian Healthcare Market Forecast to 2012
Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients
Allergy Drug Pipeline and R&D 2009
Allergy Drug Pipeline and R&D 2009
|
|
|
|
